About Us

Maruti Biogenic's mission is to become the most valued Pharma partner to the World Pharma fraternity by continuously researching, developing and manufacturing a wide range of pharmaceutical products that comply with the highest regulatory standards.

“ To become a leading and an admired global pharma company, ranked in the top 25 by 2030”

Business Overview

Founded in 2022 by Mr. Nikhil Kapuriya a small group of highly committed professionals, Maruti Biogenic was born of a vision. The company commenced operations in 2022-23 with a single unit manufacturing Carbamazepine Or Oxcarbazepine at Ankleshwar.

In addition to being the market leader in Atorvastatin Calcium Or Rosuvastatin Calcium , Maruti Biogenic has a presence in key therapeutic segments such as neurosciences (CNS), cardiovascular (CVS), anti-retroviral, anti-diabetics, gastroenterology and Anti-biotics

Through cost effective manufacturing capabilities and a few loyal customers, the company also entered the high margin specialty generic formulations segment. Today Maruti Biogenic has evolved into a knowledge driven company manufacturing active pharmaceutical ingredients and formulation products. It is R&D focused and has a multi-product portfolio with manufacturing facilities in several countries.

The formulation business is systematically organized with a divisional structure, and has a focused team for key international markets. Leveraging its large manufacturing infrastructure for APIs and formulations, wide and diversified basket of products and confidence of its customers, Maruti Biogenic achieved revenue of INR 1 To 10 Crore in FY2022-23.